Bisphenol A diglycidyl ether‐induced apoptosis involves Bax/Bid‐dependent mitochondrial release of apoptosis‐inducing factor (AIF), cytochrome c and Smac/DIABLO

No abstract is available for this paper.

• Publication year

  2003

• Venue

  British Journal of Pharmacology

• Publication date

  2003-06-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1038/sj.bjp.0705275PMID 12788809PMCID PMC1573874
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Caspase-2 Induces Apoptosis by Releasing Proapoptotic Proteins from Mitochondria*

  2002cited by this paper
• TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO.

  2002cited by this paper
• Bisphenol A diglycidyl ether induces apoptosis in tumour cells independently of peroxisome proliferator-activated receptor-gamma, in caspase-dependent and -independent manners.

  2002cited by this paper
• An Inducible Pathway for Degradation of FLIP Protein Sensitizes Tumor Cells to TRAIL-induced Apoptosis*

  2002cited by this paper
• Cell death inhibition: keeping caspases in check.

  2001cited by this paper
• Bax and other pro-apoptotic Bcl-2 family "killer-proteins" and their victim the mitochondrion

  2001cited by this paper
• Organelle-specific initiation of cell death pathways

  2001cited by this paper
• Sipunculan ParaHox genes

  2001cited by this paper
• Apoptosis-linked gene 2 binds to the death domain of Fas and dissociates from Fas during Fas-mediated apoptosis in Jurkat cells.

  2001cited by this paper
• A Synthetic Antagonist for the Peroxisome Proliferator-activated Receptor γ Inhibits Adipocyte Differentiation*

  2000cited by this paper
• PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer.

  2000cited by this paper
• PPAR-γ agonists: therapeutic role in diabetes, inflammation and cancer

  2000cited by this paper
• Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c

  2000cited by this paper
• Regulation of TRAIL-induced apoptosis by transcription factors.

  2000cited by this paper
• Mitochondrio‐nuclear translocation of AIF in apoptosis and necrosis

  2000cited by this paper
• Bisphenol A diglycidyl ether (BADGE) is a PPARγ agonist in an ECV304 cell line

  2000cited by this paper
• Molecular characterization of mitochondrial apoptosis-inducing factor

  1999cited by this paper
• Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis.

  1998cited by this paper
• Bax directly induces release of cytochrome c from isolated mitochondria.

  1998cited by this paper
• mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.

  1994cited by this paper
• Copyright � 1995, American Society for Microbiology PPAR�2 Regulates Adipose Expression of the

  1994cited by this paper
• A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolcarbocyanine iodide (JC-1).

  1993cited by this paper
• The steroid and thyroid hormone receptor superfamily.

  1988cited by this paper

• Preparation and safety assessment of BADGE- histidine adduct from epoxy-coated cans.

  2025cites this paper
• Bisphenol a Disrupts Steroidogenesis and Induces Apoptosis in Human Granulosa Cells Cultured In Vitro

  2025cites this paper
• Recent Progress on Microtubule Degradation Agents.

  2023cites this paper
• A review of properties, production, human exposure, biomonitoring, toxicity, and regulation of bisphenol A diglycidyl ethers and novolac glycidyl ethers

  2022cites this paper
• [Research on Analysis of Final Diagnosis and Prognostic Factors, and Development of New Therapeutic Drugs for Malignant Tumors (Especially Malignant Pediatric Tumors)].

  2020cites this paper
• Restore of miR-541 resensitizes pancreatic cancer cells to gemcitabine-induced apoptosis through suppression of HAX-1

  2020cites this paper
• Design, synthesis, and biological evaluation of lipophilically modified bisphenol Z derivatives

  2019cites this paper
• miR-494 Sensitizes Gastric Cancer Cells to TRAIL Treatment Through Downregulation of Survivin

  2018cites this paper
• Neurokinin-1 receptor inhibition reverses ischaemic brain injury and dementia in bilateral common carotid artery occluded rats: possible mechanisms

  2016cites this paper
• In vitro exposure of human spermatozoa to bisphenol A induces pro-oxidative/apoptotic mitochondrial dysfunction.

  2016cites this paper
• BPA qualtitative and quantitative assessment associated with orthodontic bonding in vivo.

  2015cites this paper
• Mesenchymal Stem Cells from Fetal Heart Attenuate Myocardial Injury after Infarction: An In Vivo Serial Pinhole Gated SPECT-CT Study in Rats

  2014cites this paper
• Cytotoxic effects of polycarbonate-based orthodontic brackets by activation of mitochondrial apoptotic mechanisms.

  2013cites this paper
• Active learning framework with iterative clustering for bioimage classification

  2012cites this paper
• Analogues of the epoxy resin monomer diglycidyl ether of bisphenol F: effects on contact allergenic potency and cytotoxicity.

  2012cites this paper
• Modulation of diabetic retinopathy pathophysiology by natural medicines through PPAR‐γ‐related pharmacology

  2012cites this paper
• Role of Peroxisome Proliferator Activator Receptor ó in Diabetic Retinopathy Pathophysiology

  2012cites this paper
• Cell apoptosis induced by zinc deficiency in osteoblastic MC3T3-E1 cells via a mitochondrial-mediated pathway

  2011cites this paper
• Combined treatment with the Cox-2 inhibitor niflumic acid and PPARγ ligand ciglitazone induces ER stress/caspase-8-mediated apoptosis in human lung cancer cells.

  2011cites this paper
• Nanoparticle delivery of siRNA for cancer therapy

  2010cites this paper
• Novel cationic lipid that delivers siRNA and enhances therapeutic effect in lung cancer cells.

  2009cites this paper
• Protective paracrine effect of mesenchymal stem cells on cardiomyocytes

  2009cites this paper
• PPAR gamma protects cardiomyocytes against oxidative stress and apoptosis via Bcl-2 upregulation.

  2009cites this paper
• Effects of Bisphenol-A and Other Endocrine Disruptors Compared With Abnormalities of Schizophrenia: An Endocrine-Disruption Theory of Schizophrenia

  2008cites this paper
• The bisphosphonate zoledronic acid inhibits the growth of HCT-116 colon carcinoma cells and induces tumor cell apoptosis

  2008cites this paper
• Concentrations of bisphenol a, bisphenol a diglycidyl ether, and their derivatives in canned foods in Japanese markets.

  2008cites this paper
• ReviewArticle PPARγ Inhibitors as Novel Tubulin-Targeting Agents

  2008cites this paper
• Peroxisome Proliferator-Activated Receptors (PPARs) and the Human Skin

  2008cites this paper
• PPARγ Inhibitors as Novel Tubulin-Targeting Agents

  2008cites this paper
• Ciglitazone induces caspase-independent apoptosis via p38-dependent AIF nuclear translocation in renal epithelial cells.

  2008cites this paper
• PPAR-γ inhibitors as novel tubulin-targeting agents

  2007cites this paper
• Present concepts and future outlook: Function of peroxisome proliferator‐activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer

  2007cites this paper
• CARDIOMYOCYTIC APOPTOSIS FOLLOWING GLOBAL CARDIAC ISCHEMIA AND REPERFUSION CAN BE ATTENUATED BY PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR &agr; BUT NOT &ggr; ACTIVATORS

  2006cites this paper
• Cytotoxic effects of BADGE (bisphenol A diglycidyl ether) and BFDGE (bisphenol F diglycidyl ether) on Caco-2 cells in vitro

  2006cites this paper
• Molecular symmetry: a structural property frequently present in new cytotoxic and proapoptotic drugs.

  2006cites this paper
• Minute kinetics of proapoptotic proteins: BAX and Smac/DIABLO in living tumor cells revealed by homeostatic confocal microscopy

  2004cites this paper
• GW9662, a potent antagonist of PPARγ, inhibits growth of breast tumour cells and promotes the anticancer effects of the PPARγ agonist rosiglitazone, independently of PPARγ activation

  2004cites this paper
• Kinetics of Smac/DIABLO release from mitochondria during apoptosis of MCF‐7 breast cancer cells

  2004cites this paper
• Inhibition of cell proliferation by potential peroxisome proliferator-activated receptor (PPAR) gamma agonists and antagonists.

  2004cites this paper
• ARROW@TU Dublin ARROW@TU Dublin

  year unknowncites this paper